Artesunate + amodiaquine
Pharmaceutical forms
Tablet
Country lists
ATC N/A
Composition 25 mg + 67.5 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.5.3.1. For curative treatment
  • Others observations:
    Other combinations that deliver the target doses required such as 153 mg or 200 mg (as hydrochloride) with 50 mg artesunate can be alternatives.
PAHO Strategic Fund Medicine List
2.7.2. Anti-malarial
  • Others observations:
    Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Tablet
Country lists
ATC N/A
Composition 50 mg + 135 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.5.3.1. For curative treatment
  • Others observations:
    Other combinations that deliver the target doses required such as 153 mg or 200 mg (as hydrochloride) with 50 mg artesunate can be alternatives.
PAHO Strategic Fund Medicine List
2.7.2. Anti-malarial
  • Others observations:
    Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Tablet
Country lists
ATC N/A
Composition 100 mg + 270 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.5.3.1. For curative treatment
  • Others observations:
    Other combinations that deliver the target doses required such as 153 mg or 200 mg (as hydrochloride) with 50 mg artesunate can be alternatives.
PAHO Strategic Fund Medicine List
2.7.2. Anti-malarial
  • Others observations:
    Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.